(Q39334117)

11 September 2017

Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change (English)

1 reference

11 September 2017

0 references

0 references

1 reference

Maitree Pakarasang

1

1 reference

11 September 2017

Chantapong Wasi

2

1 reference

11 September 2017

Surapol Suwanagool

3

1 reference

11 September 2017

Amphan Chalermchockcharoenkit

4

1 reference

11 September 2017

Prasert Auewarakul

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

18 January 2006

1 reference

11 September 2017

1 reference

11 September 2017

347

1 reference

11 September 2017

2

1 reference

11 September 2017

372-378

1 reference

Increase in Activated CD4+ Lymphocytes with CCR5 and CXCR4 in HIV Type 1-Infected Persons

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Target cell populations of human immunodeficiency virus type 1 in peripheral blood lymphocytes with different chemokine receptors at various stages of disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Chemokines and HIV-1 second receptors: the therapeutic connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.12.003

1 reference

11 September 2017

1 reference